NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE256461 Query DataSets for GSE256461
Status Public on Aug 08, 2024
Title miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma
Organism Canis lupus familiaris
Experiment type Non-coding RNA profiling by high throughput sequencing
Summary Urothelial carcinoma (UC) is the most common tumour type in canine bladder cancer. Current diagnostic methods are technically challenging or can lack specificity, hence there is a need for novel biomarkers of UC. To this end, we analysed the microRNA (miRNA) cargo of extracellular vesicles (EVs) from urine samples of dogs with UC to identify miRNAs that could be utilised as biomarkers. Urine was fractionated using ultrafiltration combined with size-exclusion chromatography and small RNA sequencing analysis was performed on both the EV enriched and (EV free) protein fractions. A greater number of candidate miRNA biomarkers were detected in the EV fraction than the protein fraction, and further validation using droplet digital PCR (ddPCR) was performed on the EV enriched fraction of a second cohort of dogs with bladder cancer which validated three miRNAs as candidate biomarkers; miR-182, miR-221 and miR-222 as being significantly overrepresented in dogs with UC when compared with healthy dogs and dogs with urinary tract infections. Pathway analysis confirmed that these three miRNAs are involved in cancer. In addition, their potential downstream gene targets were predicted and PIK3R1, a well-known oncogene is likely to be a shared target between miRNA-182 and miRNA-221/222. In summary, this study highlights the potential of urinary EV-associated miRNAs as a source of biomarkers for the diagnosis of canine UC.
 
Overall design To find new biomarkers for canine urithelial carcinoma from extracellular vesicle and protein SEC fraction samples isolated from dog urine. Sample groups include urothelial carcinoma (UC), urinary tract infection (UTI) and healty control (HC) samples. Eleven samples were analysed as replicates and two libraries were perepared from same RNA.
 
Contributor(s) Karttunen J, Kalmar L, Grant A, Ying J, Stewart S, Wang X, Karet Frankl F, Williams T
Citation(s) 39095540
Submission date Feb 23, 2024
Last update date Aug 08, 2024
Contact name Lajos Kalmar
E-mail(s) lk397@cam.ac.uk
Phone +441223335457
Organization name MRC Toxicology Unit, University of cambridge
Street address Tennis Court Road
City Cambridge
ZIP/Postal code CB2 1QR
Country United Kingdom
 
Platforms (1)
GPL25760 Illumina NovaSeq 6000 (Canis lupus familiaris)
Samples (56)
GSM8098780 dog_2_d_ucc_replicate1
GSM8098781 dog_2_b_ucc_replicate1
GSM8098782 dog_4_d_ucc_replicate1
Relations
BioProject PRJNA1079730

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE256461_mature_mirna_counts.csv.gz 8.8 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap